JP7809644B2 - ウイルス配列を検出するための組成物、キット、及び方法 - Google Patents

ウイルス配列を検出するための組成物、キット、及び方法

Info

Publication number
JP7809644B2
JP7809644B2 JP2022549760A JP2022549760A JP7809644B2 JP 7809644 B2 JP7809644 B2 JP 7809644B2 JP 2022549760 A JP2022549760 A JP 2022549760A JP 2022549760 A JP2022549760 A JP 2022549760A JP 7809644 B2 JP7809644 B2 JP 7809644B2
Authority
JP
Japan
Prior art keywords
seq
sars
cov
sample
probe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022549760A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023513955A (ja
JP2023513955A5 (cg-RX-API-DMAC7.html
Inventor
ケリー リ
イオアンナ パガニ
ピウス ブルゾスカ
ジシェン リ
チュンリン ワン
キャスリーン ハヤシバラ
マイケル タナー
ホン ジ
カミニ ヴァルマ
ファンチ フ
ロバート テブス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Life Technologies Corp filed Critical Life Technologies Corp
Publication of JP2023513955A publication Critical patent/JP2023513955A/ja
Publication of JP2023513955A5 publication Critical patent/JP2023513955A5/ja
Application granted granted Critical
Publication of JP7809644B2 publication Critical patent/JP7809644B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2022549760A 2020-02-18 2021-02-18 ウイルス配列を検出するための組成物、キット、及び方法 Active JP7809644B2 (ja)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US202062978274P 2020-02-18 2020-02-18
US62/978,274 2020-02-18
US202062981938P 2020-02-26 2020-02-26
US62/981,938 2020-02-26
US202063044160P 2020-06-25 2020-06-25
US63/044,160 2020-06-25
US202063052385P 2020-07-15 2020-07-15
US63/052,385 2020-07-15
US202062706081P 2020-07-30 2020-07-30
US62/706,081 2020-07-30
US202063198134P 2020-09-30 2020-09-30
US63/198,134 2020-09-30
US202063198421P 2020-10-16 2020-10-16
US63/198,421 2020-10-16
US202063199076P 2020-12-04 2020-12-04
US63/199,076 2020-12-04
US202163199570P 2021-01-08 2021-01-08
US63/199,570 2021-01-08
PCT/US2021/070163 WO2021168478A1 (en) 2020-02-18 2021-02-18 Compositions, kits and methods for detection of viral sequences

Publications (3)

Publication Number Publication Date
JP2023513955A JP2023513955A (ja) 2023-04-04
JP2023513955A5 JP2023513955A5 (cg-RX-API-DMAC7.html) 2024-02-26
JP7809644B2 true JP7809644B2 (ja) 2026-02-02

Family

ID=75540091

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022549760A Active JP7809644B2 (ja) 2020-02-18 2021-02-18 ウイルス配列を検出するための組成物、キット、及び方法

Country Status (9)

Country Link
US (3) US12637724B2 (cg-RX-API-DMAC7.html)
EP (2) EP3911769B1 (cg-RX-API-DMAC7.html)
JP (1) JP7809644B2 (cg-RX-API-DMAC7.html)
KR (1) KR102996429B1 (cg-RX-API-DMAC7.html)
CN (1) CN116113714A (cg-RX-API-DMAC7.html)
AU (1) AU2021224298A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022016493A2 (cg-RX-API-DMAC7.html)
CA (1) CA3173545A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021168478A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3089756A1 (en) 2018-01-29 2019-08-01 St. Jude Children's Research Hospital, Inc. Method for nucleic acid amplification
WO2021173310A1 (en) * 2020-02-28 2021-09-02 Avellino Lab Usa, Inc. Methods for detection of severe acute respiratory syndrome coronavirus 2
US20230130878A1 (en) * 2020-03-13 2023-04-27 The Translational Genomics Research Institute Methods and kits for the detection of sars-cov-2
WO2021183893A1 (en) * 2020-03-13 2021-09-16 The Translational Genomics Research Institute Methods and kits for the detection of sars-cov-2
WO2021202344A2 (en) * 2020-03-31 2021-10-07 Bioskryb, Inc. Detection of low abundance viruses
US20220333215A1 (en) * 2020-03-31 2022-10-20 The Hopes Institute Methods and compositions for detecting co-infection with sars-cov-2 and influenza a virus and/or influenza b virus
US20210324486A1 (en) * 2020-04-20 2021-10-21 Thomas Jefferson University Method and Primers for the Sensitive and Specific Detection of SARS-CoV-2
US20220042117A1 (en) * 2020-08-06 2022-02-10 Roche Molecular Systems, Inc. COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION OF INFLUENZA A, INFLUENZA B, AND SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
US20230366042A1 (en) * 2020-10-02 2023-11-16 Ohio State Innovation Foundation Dna nanodevice hinge biosensors and methods of use thereof
US12344889B2 (en) * 2021-03-09 2025-07-01 Transformative Biotech, Llc Extraction-free pathogen testing methods
CN113801963B (zh) * 2021-09-17 2024-03-26 佛山科学技术学院 一种检测冠状病毒的引物探针组合、试剂盒及方法
JP7825255B2 (ja) * 2021-09-22 2026-03-06 学校法人 名城大学 標的配列の検出方法及び標的配列の検出装置
CN114134143A (zh) * 2021-12-23 2022-03-04 郑州安图生物工程股份有限公司 检测标志物、引物、探针或其组合,以及检测试剂、检测试剂盒
US20230220501A1 (en) * 2022-01-13 2023-07-13 Whitworth University Pathogen detection system
JP2023121264A (ja) * 2022-02-21 2023-08-31 株式会社島津製作所 変異ウイルスの検出方法
EP4490314A1 (en) * 2022-03-10 2025-01-15 Genxpro GmbH Methods for detecting genomic variants of sars-cov-2 in multiplex assays
WO2023230590A2 (en) * 2022-05-27 2023-11-30 Bowling Green State University Dna aptamers as universal inhibitors of spike protein/hace2 interactions
EP4317459A1 (en) * 2022-08-04 2024-02-07 National and Kapodistrian University of Athens Method for the detection of sars-cov-2 by digital pcr
WO2024102839A1 (en) * 2022-11-10 2024-05-16 Life Technologies Corporation Compositions, kits, and methods for detection of viral sequences
WO2025054605A1 (en) * 2023-09-08 2025-03-13 Rhode Island Hospital Improved pcr primers for sars-cov-2 viremia

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618711A (en) 1986-08-22 1997-04-08 Hoffmann-La Roche Inc. Recombinant expression vectors and purification methods for Thermus thermophilus DNA polymerase
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US6127155A (en) 1986-08-22 2000-10-03 Roche Molecular Systems, Inc. Stabilized thermostable nucleic acid polymerase compositions containing non-ionic polymeric detergents
US5079352A (en) 1986-08-22 1992-01-07 Cetus Corporation Purified thermostable enzyme
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
US5436134A (en) 1993-04-13 1995-07-25 Molecular Probes, Inc. Cyclic-substituted unsymmetrical cyanine dyes
US5658751A (en) 1993-04-13 1997-08-19 Molecular Probes, Inc. Substituted unsymmetrical cyanine dyes with selected permeability
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
US6821727B1 (en) 1993-11-15 2004-11-23 Applera Corporation Hybridization assay using self-quenching fluorescence probe
US5801155A (en) 1995-04-03 1998-09-01 Epoch Pharmaceuticals, Inc. Covalently linked oligonucleotide minor grove binder conjugates
US5773258A (en) 1995-08-25 1998-06-30 Roche Molecular Systems, Inc. Nucleic acid amplification using a reversibly inactivated thermostable enzyme
EP1130114A1 (en) 2000-03-03 2001-09-05 Dr. van Haeringen Laboratorium B.V. Universal variable fragments
EP2345738A1 (en) 2002-08-05 2011-07-20 Quanta Biosciences, Inc. Improved compositions for in vitro amplification of nucleic acids
BRPI0413825A (pt) 2003-08-22 2006-10-24 Birch Biomedical Res Llc detecção molecular multialélica de coronavìrus associado com sars
EP2049688B1 (en) 2006-08-01 2018-01-24 Applied Biosystems, LLC Detection of analytes and nucleic acids
US20090269816A1 (en) 2007-10-05 2009-10-29 Sapphire Energy, Inc. System for capturing and modifying large pieces of genomic DNA and constructing organisms with synthetic chloroplasts
WO2010030936A2 (en) 2008-09-12 2010-03-18 Mount Sinai School Of Medicine Of New York University Novel autophagy regulators atg14l and rubicon
CN101812532A (zh) * 2009-02-24 2010-08-25 江苏默乐生物科技有限公司 呼吸道合胞病毒、腺病毒、副流感病毒和流感病毒检测引物和探针
AU2010308329B2 (en) 2009-10-19 2016-10-13 Labrador Diagnostics Llc Integrated health data capture and analysis system
KR20130043104A (ko) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들
MX345557B (es) 2011-07-06 2017-02-02 Quest Diagnostics Invest Inc Amplificacion y deteccion directa de patogenos virales y bacteriales.
US10253353B2 (en) 2013-12-06 2019-04-09 The Broad Institute, Inc. Enhanced methods of ribonucleic acid hybridization
WO2017088169A1 (en) 2015-11-27 2017-06-01 Coyote Bioscience Co., Ltd. Methods and systems for nucleic acid amplification
CN110468237B (zh) 2016-03-10 2023-06-30 广州达安基因股份有限公司 检测中东呼吸综合征冠状病毒的引物探针混合液及试剂盒
CN111406119A (zh) 2017-06-28 2020-07-10 克罗玛科德公司 使用微滴式pcr系统的多重荧光测量
CN111566203A (zh) 2017-12-04 2020-08-21 克罗莫依安私人有限公司 包括用于性别选择的材料和方法
US11242544B2 (en) 2018-07-11 2022-02-08 Wisconsin Alumni Research Foundation Microbiomes and methods for producing medium-chain fatty acids from organic substrates
WO2020023612A1 (en) 2018-07-24 2020-01-30 Voyager Therapeutics, Inc. Systems and methods for producing gene therapy formulations
GB201812428D0 (en) 2018-07-31 2018-09-12 Bg Res Ltd Improved method for pathogen detection
JP2020080806A (ja) 2018-11-30 2020-06-04 株式会社島津製作所 Rnaウイルス検出方法
KR102018201B1 (ko) 2019-05-01 2019-09-06 대한민국 리얼타임 pcr을 이용한 박쥐 유래 코로나바이러스 검사 키트 및 방법
EP3977461A4 (en) 2019-05-24 2023-06-28 Clear Labs, Inc. Methods and kits for detecting pathogens
JP7713130B2 (ja) 2019-09-30 2025-07-25 イーライ リリー アンド カンパニー 遺伝性難聴の処置のためのアデノ随伴ウイルス(aav)システム
CN111088405A (zh) * 2020-02-06 2020-05-01 苏州行知康众生物科技有限公司 用于检测冠状病毒2019-nCoV的引物探针组合物、试剂盒及方法
WO2021159020A2 (en) * 2020-02-06 2021-08-12 Mammoth Biosciences, Inc. Compositions and methods for detection of coronavirus
CN111172239A (zh) 2020-02-28 2020-05-19 上海思路迪医学检验所有限公司 一种病毒样本保存液、核酸提取试剂及病毒核酸提取方法
CN111172327A (zh) 2020-03-05 2020-05-19 杭州丹威生物科技有限公司 一种免提取新型冠状病毒核酸检测的方法与试剂盒
WO2021174742A1 (zh) 2020-03-06 2021-09-10 生物岛实验室 一种动物的制备方法
CN111270013A (zh) * 2020-03-12 2020-06-12 宁波海尔施基因科技有限公司 一种检测2019新型冠状病毒的多重实时荧光定量pcr试剂盒、方法及引物探针组合物
CN111304368A (zh) 2020-03-19 2020-06-19 艾康生物技术(杭州)有限公司 用于检测新型冠状病毒的方法、寡核苷酸和试剂盒
CN111394513B (zh) 2020-03-24 2023-05-12 中国医学科学院病原生物学研究所 新型冠状病毒SARS-CoV-2荧光定量PCR检测方法及其应用
CN111206121A (zh) 2020-03-31 2020-05-29 江苏达伯药业有限公司 一种用于检测新型冠状病毒orflab和S基因的试剂盒
CN111321252B (zh) 2020-04-17 2021-06-15 山东仕达思生物产业有限公司 一种具有抗突变性能的新型冠状病毒核酸检测引物对、试剂盒及其应用
CN111394431B (zh) 2020-05-26 2023-03-21 鲲石生物科技(深圳)有限公司 一种使用双重实时荧光等温扩增技术检测核酸的方法
CN111471803A (zh) 2020-05-29 2020-07-31 武汉生命之美科技有限公司 一种新型冠状病毒covid-19感染检测试剂盒
CN111808988A (zh) 2020-06-09 2020-10-23 广州市金圻睿生物科技有限责任公司 一种covid-19核酸释放剂及核酸检测试剂盒
CN111748649A (zh) 2020-06-13 2020-10-09 上海同进基因科技有限公司 一种同时检测人流感病毒与新型冠状病毒的荧光定量检测试剂盒
CN111676325A (zh) 2020-07-07 2020-09-18 云南科耀生物科技有限公司 一种用于检测SARS-CoV-2全基因组的引物组合及应用方法
CN111850166A (zh) 2020-07-10 2020-10-30 中国人民解放军总医院第五医学中心 一种大规模筛查新型冠状病毒感染人群的核酸检测方法及应用
CN112126713A (zh) 2020-07-16 2020-12-25 上海之江生物科技股份有限公司 一种冠状病毒和流感病毒联合检测产品及其用途
CN111733290A (zh) 2020-07-16 2020-10-02 北京贝尔生物工程股份有限公司 一种检测新型冠状病毒及近缘冠状病毒的试剂盒及其制备方法
CN117051018A (zh) 2020-07-25 2023-11-14 上海市公共卫生临床中心 一种埃博拉病毒的靶点序列及其应用
CN111808995A (zh) 2020-07-29 2020-10-23 江苏宏微特斯医药科技有限公司 一种呼吸道病原体核酸检测试剂盒
CN111733295B (zh) 2020-07-31 2021-03-23 广州领上源生物科技有限公司 用于检测新型冠状病毒的引物组及试剂盒
CN111778362A (zh) 2020-08-10 2020-10-16 深圳容金科技有限公司 一种冻干的新型冠状病毒、流感病毒、肺炎病毒核酸检测试剂盒与检测方法
CN111996290A (zh) 2020-08-21 2020-11-27 上海交通大学医学院附属第九人民医院 基于多重PCR的SARS-CoV-2全基因组核酸扩增特异性引物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Euro Surveill.,2020年01月,25(3),2000045,p.1-8,doi: 10.2807/1560-7917.ES.2020.25.3.2000045
The Lancet(Epub 2020 Jan 30),2020年01月30日,395(10224),p.565-574

Also Published As

Publication number Publication date
US20220186328A1 (en) 2022-06-16
EP3911769B1 (en) 2022-11-02
US11214843B2 (en) 2022-01-04
EP4056719A1 (en) 2022-09-14
US20210292857A1 (en) 2021-09-23
CA3173545A1 (en) 2021-08-26
US12637724B2 (en) 2026-05-26
BR112022016493A2 (pt) 2022-10-25
KR20220155998A (ko) 2022-11-24
WO2021168478A1 (en) 2021-08-26
CN116113714A (zh) 2023-05-12
KR102996429B1 (ko) 2026-07-28
US12065707B2 (en) 2024-08-20
US20210292856A1 (en) 2021-09-23
JP2023513955A (ja) 2023-04-04
AU2021224298A1 (en) 2022-09-22
EP3911769A1 (en) 2021-11-24

Similar Documents

Publication Publication Date Title
US12065707B2 (en) Compositions, kits and methods for detection of viral sequences
CN114058679B (zh) 一种crispr级联核酸检测系统及其检测方法与应用
Shen et al. Recent advances and perspectives of nucleic acid detection for coronavirus
Huang et al. Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis
CN116171333A (zh) 用于检测严重急性呼吸综合征冠状病毒2(sars-cov-2)、甲型流感和乙型流感的组合物和方法
Tang et al. Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms
Ma et al. FEN1-aided recombinase polymerase amplification (FARPA) for one-pot and multiplex detection of nucleic acids with an ultra-high specificity and sensitivity
Zhan et al. High-throughput two-dimensional polymerase chain reaction technology
US20240392394A1 (en) Compositions, kits and methods for detection of viral variant sequences
WO2024102839A1 (en) Compositions, kits, and methods for detection of viral sequences
Wan et al. Rapid, highly specific and sensitive detection of human adenovirus using multiple cross displacement amplification coupled with CRISPR-Cas12a-based detection
US20240124947A1 (en) Compositions for coronavirus detection and methods of making and using therof
CN120457221A (zh) 用于检测病毒序列的组合物、试剂盒和方法
EP4547875A1 (en) Multiplex panel for upper respiratory pathogens
CN118414438A (zh) 使用内部定量标准物定量核酸序列的组合物、试剂盒和方法
RU2825283C1 (ru) Композиции, наборы и способы для обнаружения вирусных последовательностей
WO2022047127A1 (en) Compositions and methods for detection of coronavirus
Basit et al. Nucleic Acid-Based Detection of COVID-19
BR122024001965A2 (pt) Composição para amplificar sequências-alvo no genoma de sars-cov- 2, método para detectar sars-cov-2 em uma amostra biológica e kit para realizar um ensaio para a detecção e identificação de ácidos nucleicos alvo em uma amostra
US20250333806A1 (en) Compositions, kits, and methods for variant-resistant detection of target viral sequences
US20240352544A1 (en) Compositions, kits, and methods for detection of nucleic acid sequence loads
Zhang et al. A Critical Review of the CRISPR‐Cas Technology in the Detection of SARS‐CoV‐2 Variants
US20240254568A1 (en) Compositions, kits, and methods for detecting sti pathogen sequences
WO2024054925A1 (en) Compositions, kits and methods for detection of viral variant sequences
WO2025160423A1 (en) Multiplex panel for detecting gastrointestinal viral nucleic acids

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240215

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240215

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250421

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250718

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251021

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20251222

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260121

R150 Certificate of patent or registration of utility model

Ref document number: 7809644

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150